ANI PHARMACEUTICALS, INC (ANIP) Capital expenditures 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$13.8MFY2025 · since FY2016: $4.6M → $13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.8M | -14.8% |
| FY2024 | $16.2M | +83.1% |
| FY2023 | $8.9M | -0.1% |
| FY2022 | $8.9M | +247.1% |
| FY2021 | $2.6M | -58.3% |
| FY2020 | $6.1M | -7.5% |
| FY2019 | $6.6M | +15.5% |
| FY2018 | $5.7M | -44.6% |
| FY2017 | $10.4M | +127.1% |
| FY2016 | $4.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice